BioAdaptives Inc (BDPT PINK) stock market data APIs
$0.0287
-0.01(-34.8%)
as of December 19, 2025
Try our APIs with
free plan!
BioAdaptives Inc Financial Data Overview
Price chart is built with
Anychart
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. The company was incorporated in 2013 and is based in Las Vegas, Nevada.
Prev. Close
0.0287
Open
0.0175
High
0.0287
Low
0.0174
52 wk Range
0.0132-0.13
Market Cap
348 K
Shares Outstanding
12 009 K
Revenue
7 851
EPS
-0.04
Beta
1.035
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BioAdaptives Inc data using free add-ons & libraries
Get BioAdaptives Inc Fundamental Data
BioAdaptives Inc Fundamental data includes:
- Net Revenue: 7 851
- EBITDA: -1 128 895
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioAdaptives Inc News
New
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced the commercial availability of MyndMed™, a next-generation cognitive-support dietary suppleme...
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety
LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTCMKTS: BDPT), a leader in natural health and performance supplements, today announced that its flagship nootropic formu...
BioAdaptives Announces National Launch of Pawpa™ Regen
LAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC Pink: BDPT), an innovator in nutraceutical and wellness science, today announces the upcoming national release of Paw...
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
VeganHepPlusTM is Designed to Detoxify the Liver and Support Healthy Function The American Association for the Study of Liver Diseases Predict Increase in Chronic Liver Disease Over the Next 25 Years...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
